Depression Among Individuals with Irritable Bowel Syndrome: A Nationwide Claims-Based Analysis of 3.9 Million Koreans

韩国390万人口的全国性医疗保险索赔数据分析:肠易激综合征患者的抑郁症研究

阅读:1

Abstract

Background/Objectives: While a growing body of research indicates an increased psychiatric burden, including depression comorbidity, among individuals with irritable bowel syndrome (IBS), evidence from large claim-based databases remains limited. This study aimed to investigate the association between IBS and depression among a nationally representative sample of 3.9 million Korean adults. Methods: We used data from the 2021 Korean National Health Insurance Service (NHIS), including a total of 3,864,586 individuals aged 19-64 years who participated in the national biennial health screening exam between 1 January 2021 and 31 December 2021. Exposures and outcomes were identified based on the International Classification of Diseases, Tenth Revision (ICD-10), codes: F32 and F33 for depression and K58 for IBS. Multivariable logistic regression analysis adjusted for age, sex, residential area, comorbidity, smoking, alcohol use, physical activity, and body mass index was conducted. Results: One-year prevalence of depression among the entire sample was 4.0%. The prevalence among individuals with IBS (7.3%) was significantly higher than that among those without IBS (3.6%, p < 0.001). Multivariable logistic regression analysis confirmed this relationship (OR = 1.77, 95% CI: 1.74, 1.79) after adjusting for all covariates. Conclusions: Our findings suggest that individuals with IBS are vulnerable to depression, emphasizing the need for integrated approaches in clinical management and public health policy responding to the rising burden of IBS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。